Sohail Asif Qureshi

From a home for articles deleted from Wikipedia
Revision as of 12:18, 30 December 2017 by Robyt (talk | contribs) (inclusion power)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
This article needs additional references for verification. Please help[0] improve this article by adding citations to reliable sources. Unsourced material will not be challenged and removed. (December 2017)
This article was considered for deletion at Wikipedia on December 28 2017. This is a backup of Wikipedia:Sohail_Asif_Qureshi. All of its AfDs can be found at Wikipedia:Special:PrefixIndex/Wikipedia:Articles_for_deletion/Sohail_Asif_Qureshi, the first at Wikipedia:Wikipedia:Articles_for_deletion/Sohail_Asif_Qureshi. Purge

Template:Like resume

File:Sohail Qureshi.jpg
Sohail Qureshi at CECOS university

Sohail Asif Qureshi (also Sohail Qureshi or Sohail A. Qureshi) (born May 21, 1963) is a Pakistani molecular biologist and professor of biology at CECOS University in Peshawar, Pakistan. His research interests include gene regulation in hyperthermophilic archaea, Hepatitis C, Hepatitis E, cancer, epigenomics and neuroscience. He was involved in the discovery of the B recognition element in Archaea.

Life and education

Sohail Qureshi received a master's degree in biology from Quaid-i-Azam University, Islamabad in 1984. He received a PhD in molecular biology in 1990 from University of Maine under the supervision of Richard D. Blake.[1]

Professional and academic career

Qureshi was a Postdoctoral Research Associate in Howard T. Jacob’s laboratory from 1990-1993 in the Institute of Genetics at University of Glasgow, Scotland. Research he was involved in included protein-DNA interactions in sea urchin mitochondria. He identified several sequence-specific DNA-binding proteins capable of regulating sea urchin mitochondrial DNA replication and transcription. From July 1993 to April 1994 he was a Postdoctoral Fellow in D. Bentley’s laboratory at Imperial Cancer Research Fund, London. In April 1994, he joined the CRC Institute, now the Wellcome Trust/Cancer Research UK Gurdon Institute at Cambridge University, U.K. as a Senior Research Fellow and worked in Steve Jackson’s laboratory on the transcriptional apparatus in Sulfolobus shibatae.

Following this, Qureshi spent almost to four years at University of Wisconsin-Madison in the Department of Neurology, where he identified more than fifty novel genes and studied the function(s) of two novel transcription factors in great detail. This work resulted in a patent which helped establish NeuroGenomeX (a company dedicated to identifying and validating genes/proteins involved in neuronal plasticity) in early 1999. While in Madison, Wisconsin, he was recruited by Invitrogen Corporation as a Senior R&D Scientist from 2001-2003.

In 2004, Sohail Qureshi joined Aga Khan University in Karachi, Pakistan where he was the Jafferali Lalji Professor till 2010 at the Department of Biological and Biomedical Science. He developed a research group at the University and taught courses to both medical and postgraduate students. From 2006-2007, he was also a visiting professor at the Centre for Innovations in Medicine, Biodesign Institute, Arizona State University where he was involved in the area of genetic vaccines.[2]

Committee memberships

Sohail Qureshi was a member of Board of governors for the Centre of Excellence in Molecular Biology (CEMB), Punjab University. He was a member of the Aga Khan University Ethical Review Committee from April 2005 to December 2015. He was involved with Aga Khan University, FHS PhD Committee. Qureshi was the Chairman of AKU Sports and Rehabilitation Centre Advisory Committee and was also involved in the Neuroscience Module Committee and the AKU Faculty of Arts and Sciences Curriculum Advisory Committee.